Search
Search Results
##search.searchResults.foundPlural##
-
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
2927PDF: 977HTML: 7405 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1426PDF: 712HTML: 1138Untitled: 191Untitled: 156Untitled: 141Untitled: 161Untitled: 170 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4607PDF: 1957HTML: 17934 -
DISSEMINATED HISTOPLASMOSIS IN IMMUNOCOMPETENT INDIVIDUALS- NOT A SO RARE ENTITY
2445PDF: 1120HTML: 2177Untitled: 181 -
FAMILIAL MEDITERRANEAN FEVER AND HYPERCOAGULABILITY
1246PDF: 727HTML: 1249 -
CRYOGLOBULIN TEST AND CRYOGLOBULINEMIA HEPATITIS C-VIRUS RELATED
4010PDF: 1325HTML: 2357 -
Identification of Alpha Thalassemia, RNF 213 p.R4810K and PROC p.R189W among Children with Moyamoya Disease/Syndrome Alpha Thalassemia and RNF 213 Gene Mutation in Moyamoya
1004PDF: 751HTML: 244 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1301PDF: 1046HTML: 298 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2866PDF: 1851HTML: 3704Pellagatti Fig 1: 230Pellagatti Fig. 2: 224 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
871PDF: 490HTML: 1310 -
COMPARATIVE ANALYSIS OF CLINICAL AND LABORATORY DATA IN CHILDREN WITH MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED WITH SARS-COV-2 IN THE REPUBLIC OF KAZAKHSTAN MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED WITH SARS-COV-2
1110PDF: 584HTML: 359 -
PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN HBV,HCV and HIV and Sickle Cell Disease.
1682PDF: 1025HTML: 439 -
EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies
1744PDF: 751HTML: 237 -
-
ROLE OF CYTOKINES AS MOLECULAR MARKER OF DENGUE SEVERITY
3235PDF: 1193HTML: 474 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3430PDF: 1503HTML: 4040 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1392PDF: 1032HTML: 128 -
DISTRIBUTION OF DNA DAMAGE REPAIR GENE POLYMORPHISM hOGG1, XRCC1 and p53 AMONG SICKLE CELL DISEASE PATIENTS IN INDIA
1585PDF: 800HTML: 1504Table Genotype and allele frequencies of hOGG1 codon 326 Ser>Cys and p53 72Arg>Pro polymorphisms among SCD patients and control group: 186 -
-
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1432HTML: 545PDF: 854 -
TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL
7178PDF: 4031HTML: 24919 -
Kikuchi-Fujimoto disease and hemophagocytic lymphohistiocytosis: a rare combination of two rare diseases
913PDF: 661Suppl. Files: 135HTML: 119 -
DETECTION OF ANTINUCLEAR ANTIBODIES TARGETING INTRACELLULAR SIGNAL TRANSDUCTION, METABOLISM, APOPTOTIC PROCESSES AND CELL DEATH IN CRITICAL COVID-19 PATIENTS
1409PDF: 1040HTML: 393Suppl. Figure: 190Suppl. Tables: 213 -
ULTRASOUND AS FIRST LINE STEP IN ANAEMIA DIAGNOSTICS
1443PDF: 904HTML: 1885 -
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1344PDF: 757HTML: 361 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4324PDF: 1544HTML: 462 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
1911HTML: 1550PDF: 1129 -
A 9month-old-boy with atypical hemophagocytic lymphohistiocytosis
2065PDF: 818HTML: 1171 -
IRON DEFICIENCY ANAEMIA AMONG PRE-SCHOOL CHILDREN WITH SICKLE CELL ANAEMIA: STILL A RARE DIAGNOSIS?
1407PDF: 841HTML: 2940cover leer: 156







